Biotech NewsBreakthrough Immunotherapy From Agenus (AGEN) Targets Toughest Tumors in 2025 BioTech Health XMay 27, 2025 Agenus Inc. (NASDAQ:AGEN) is emerging as one of the most promising biotech companies focused on immuno-oncology, with a… 0 Shares 0 0 0 0 0 0 0